Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (Europe)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (Europe)
Ukraine war briefing : Energy war continues with strikes on Russian oil and gas plants
20/10/2025
Rodrigo Paz Pereira wins Bolivia’s presidential runoff marking a new shift to the right
20/10/2025
Hong Kong : two people reported killed after cargo plane skids off airport runway
20/10/2025
America, there is still so much to love about you but we have to break up. This is why I’m renouncing US citizenship | Anonymous
20/10/2025
Millions exploited by ‘menopause gold rush’ amid lack of reliable information, say experts
20/10/2025
Housing market slows amid fears Reeves will increase property taxes
20/10/2025